Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Debt Issuances (2019 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 8 years of Long-Term Debt Issuances data on record, last reported at $31.8 million in Q3 2024.

  • For Q3 2024, Long-Term Debt Issuances changed N/A year-over-year to $31.8 million; the TTM value through Aug 2024 reached $348.0 million, changed N/A, while the annual FY2025 figure was $128.6 million, 14.05% down from the prior year.
  • Long-Term Debt Issuances reached $31.8 million in Q3 2024 per LFCR's latest filing, down from $149.6 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $150.0 million in Q1 2021 and bottomed at $20.0 million in Q2 2021.
  • Average Long-Term Debt Issuances over 4 years is $86.3 million, with a median of $89.2 million recorded in 2023.
  • Peak YoY movement for Long-Term Debt Issuances: changed 0.0% in 2022, then skyrocketed 633.16% in 2023.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $20.0 million in 2021, then changed by 0.0% to $20.0 million in 2022, then surged by 633.16% to $146.6 million in 2023, then plummeted by 78.3% to $31.8 million in 2024.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $31.8 million in Q3 2024, $149.6 million in Q2 2024, and $146.6 million in Q2 2023.